Respiratory Research (Apr 2011)

CD8 positive T cells express IL-17 in patients with chronic obstructive pulmonary disease

  • Eidelman David H,
  • Maltais François,
  • Bourbeau Jean,
  • Boulais Nicholas,
  • Nadigel Jessica,
  • Chang Ying,
  • Hamid Qutayba

DOI
https://doi.org/10.1186/1465-9921-12-43
Journal volume & issue
Vol. 12, no. 1
p. 43

Abstract

Read online

Abstract Background Chronic obstructive pulmonary disease (COPD) is a progressive and irreversible chronic inflammatory disease of the lung. The nature of the immune reaction in COPD raises the possibility that IL-17 and related cytokines may contribute to this disorder. This study analyzed the expression of IL-17A and IL-17F as well as the phenotype of cells producing them in bronchial biopsies from COPD patients. Methods Bronchoscopic biopsies of the airway were obtained from 16 COPD subjects (GOLD stage 1-4) and 15 control subjects. Paraffin sections were used for the investigation of IL-17A and IL-17F expression in the airways by immunohistochemistry, and frozen sections were used for the immunofluorescence double staining of IL-17A or IL-17F paired with CD4 or CD8. In order to confirm the expression of IL-17A and IL-17F at the mRNA level, a quantitative RT-PCR was performed on the total mRNA extracted from entire section or CD8 positive cells selected by laser capture microdissection. Results IL-17F immunoreactivity was significantly higher in the bronchial biopsies of COPD patients compared to control subjects (P P P P Conclusion These findings support the notion that Th17 cytokines could play important roles in the pathogenesis of COPD, raising the possibility of using this mechanism as the basis for novel therapeutic approaches.

Keywords